Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OptimizeRx CorpOPRX · Entity 213 | CHIEF FINANCIAL OFFICER | October 05, 2021 | October 05, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OptimizeRx Corp
Report date October 05, 2021 · Filed October 05, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (pursuant to 10B5-1 plan)SEC Table I · non-derivative | Direct | 34,796 |
Reported balance
After 2021-10-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-10-05 · Sale · Disposed 4,000 · Balance 34,796 F2: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| Common Stock (pursuant to 10B5-1 plan)SEC Table I · non-derivative | Direct | 34,796 |
Reported balance
After 2021-10-05 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2021-10-05 · Sale · Disposed 10,000 · Balance 34,796 F1: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | Direct | 44,796 |
Reported balance
After 2021-10-05 transaction · row 2
1 source rowRow 2 · 2021-10-05 · Exercise / conversion · Acquired 10,000 · Balance 44,796 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $7.51 · Expires 2025-03-11 | Direct | 34,699 |
Reported balance
After 2021-10-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-10-05 · Exercise / conversion · Disposed 10,000 · Balance 34,699 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2021 Filed Oct 5, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 10,000 | $7.51 Strike: $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-051449 · ownership.xml · derivative · entry 4 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,699 Underlying: Common Stock · 10,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 10,000 | $82.35 | $823,500.00 |
DisclosureSEC source: 0001213900-21-051449 · ownership.xml · nonDerivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 10,000 | $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-051449 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $84.22 | $336,880.00 |
DisclosureSEC source: 0001213900-21-051449 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,796 F2 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 28, 2021 Filed Sep 29, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 2,000 | $74.66 | $149,320.00 |
DisclosureSEC source: 0001213900-21-050600 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $70.59 | $282,360.00 |
DisclosureSEC source: 0001213900-21-049366 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 3,768 | $65.57 | $247,067.76 |
DisclosureSEC source: 0001213900-21-048250 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 10,000 | $7.51 Strike: $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-047223 · ownership.xml · derivative · entry 4 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,699 Underlying: Common Stock · 10,000 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 10,000 | $67.25 | $672,500.00 |
DisclosureSEC source: 0001213900-21-047223 · ownership.xml · nonDerivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,564 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 10,000 | $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-047223 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 07, 2021 Filed Sep 9, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 2,232 | $70.53 | $157,422.96 |
DisclosureSEC source: 0001213900-21-047223 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,564 F2 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $66.62 | $266,480.00 |
DisclosureSEC source: 0001213900-21-046409 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 24, 2021 Filed Aug 24, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $61.50 | $246,000.00 |
DisclosureSEC source: 0001213900-21-044609 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,796 F2 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 5,000 | $58.45 | $292,250.00 |
DisclosureSEC source: 0001213900-21-044609 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on June 18, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 17, 2021 Filed Aug 17, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $58.46 | $233,840.00 |
DisclosureSEC source: 0001213900-21-043479 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,796 F2 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 5,000 | $63.27 | $316,350.00 |
DisclosureSEC source: 0001213900-21-043479 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on June 18, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 10, 2021 Filed Aug 10, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 2,000 | $64.50 | $129,000.00 |
DisclosureSEC source: 0001213900-21-041400 · ownership.xml · nonDerivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,796 F2 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 10,000 | $7.51 Strike: $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-041400 · ownership.xml · derivative · entry 4 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,699 Underlying: Common Stock · 10,000 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 10,000 | $7.51 | $75,100.00 |
DisclosureSEC source: 0001213900-21-041400 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 10,000 | $64.31 | $643,100.00 |
DisclosureSEC source: 0001213900-21-041400 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| August 03, 2021 Filed Aug 3, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 2,000 | $54.93 | $109,860.00 |
DisclosureSEC source: 0001213900-21-040133 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 27, 2021 Filed Jul 28, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 3,000 | $52.58 | $157,740.00 |
DisclosureSEC source: 0001213900-21-039109 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 20, 2021 Filed Jul 21, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 3,000 | $50.90 | $152,700.00 |
DisclosureSEC source: 0001213900-21-037938 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 13,435 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001213900-21-036374 · ownership.xml · derivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,699 Underlying: Common Stock · 13,435 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 13,435 | $2.46 | $33,050.10 |
DisclosureSEC source: 0001213900-21-036374 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 13,435 | $56.05 | $753,031.75 |
DisclosureSEC source: 0001213900-21-036374 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,361 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 3,421 | $63.00 | $215,523.00 |
DisclosureSEC source: 0001213900-21-035072 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,796 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 4,000 | $60.00 | $240,000.00 |
DisclosureSEC source: 0001213900-21-034239 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,217 F1 · security: These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 14,500 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001213900-21-031479 · ownership.xml · derivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,134 Underlying: Common Stock · 14,500 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 14,500 | $2.46 | $35,670.00 |
DisclosureSEC source: 0001213900-21-031479 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock (pursuant to 10B5-1 plan) | 14,500 | $52.62 | $762,990.00 |
DisclosureSEC source: 0001213900-21-031479 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,717 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 18, 2021 Filed May 19, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 14,500 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001213900-21-027935 · ownership.xml · derivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,634 Underlying: Common Stock · 14,500 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 19, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 14,500 | $2.46 | $35,670.00 |
DisclosureSEC source: 0001213900-21-027935 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2021 Filed May 19, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock | 14,500 | $45.85 | $664,825.00 |
DisclosureSEC source: 0001213900-21-027935 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,717 F1 · security: These shares sold pursuant to a plan of disposition adopted on March 24, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 29, 2021 Filed Jan 29, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 4,315 | $7.51 Strike: $7.51 | $32,405.65 |
DisclosureSEC source: 0001213900-21-005406 · ownership.xml · derivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,134 Underlying: Common Stock · 4,315 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2021 Filed Jan 29, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 4,315 | $7.51 | $32,405.65 |
DisclosureSEC source: 0001213900-21-005406 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2021 Filed Jan 29, 2021 16:46 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock | 5,032 | $47.25 | $237,762.00 |
DisclosureSEC source: 0001213900-21-005406 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,902 F1 · security: These shares sold pursuant to a plan of disposition adopted on September 22, 2020 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. This sale completes the plan. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 5,000 | $7.51 Strike: $7.51 | $37,550.00 |
DisclosureSEC source: 0001213900-21-002568 · ownership.xml · derivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,993 Underlying: Common Stock · 5,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 5,000 | $7.51 | $37,550.00 |
DisclosureSEC source: 0001213900-21-002568 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2021 Filed Jan 15, 2021 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock | 5,000 | $38.89 | $194,450.00 |
DisclosureSEC source: 0001213900-21-002568 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,937 F1 · security: These shares sold pursuant to a plan of disposition adopted on September 22, 2020 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 19:04 UTC | OptimizeRx Corp OPRX · Entity 213 | GrantStock Option · Derivative | 14,456 | $0.00 Strike: $37.50 | $0.00 |
DisclosureSEC source: 0001213900-21-001537 · ownership.xml · derivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,449 Underlying: Common Stock · 14,456 shares Expires 2024-01-07 F1 · derivative.exercise_date: The Stock Option will vest 1/3 at the end of each anniversary from issuance. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 16:47 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 4,000 | $7.51 Strike: $7.51 | $30,040.00 |
DisclosureSEC source: 0001213900-21-000459 · ownership.xml · derivative · entry 5 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,993 Underlying: Common Stock · 4,000 shares Expires 2025-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 16:47 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 4,566 | $2.46 Strike: $2.46 | $11,232.36 |
DisclosureSEC source: 0001213900-21-000459 · ownership.xml · derivative · entry 4 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,993 Underlying: Common Stock · 4,566 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 16:47 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 4,000 | $7.51 | $30,040.00 |
DisclosureSEC source: 0001213900-21-000459 · ownership.xml · nonDerivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 16:47 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 4,566 | $2.46 | $11,232.36 |
DisclosureSEC source: 0001213900-21-000459 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 16:47 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock | 8,334 | $32.88 | $274,021.92 |
DisclosureSEC source: 0001213900-21-000459 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,371 F1 · security: These shares sold pursuant to a plan of disposition adopted on September 22, 2020 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 17:05 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 15,000 | $2.46 Strike: $2.46 | $36,900.00 |
DisclosureSEC source: 0001213900-20-036981 · ownership.xml · derivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,559 Underlying: Common Stock · 15,000 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 13, 2020 17:05 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionCommon Stock | 15,000 | $2.46 | $36,900.00 |
DisclosureSEC source: 0001213900-20-036981 · ownership.xml · nonDerivative · entry 2 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 17:05 UTC | OptimizeRx Corp OPRX · Entity 213 | SaleCommon Stock | 15,000 | $24.05 | $360,750.00 |
DisclosureSEC source: 0001213900-20-036981 · ownership.xml · nonDerivative · entry 1 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,705 F1 · security: These shares sold pursuant to a plan of disposition adopted on June 16, 2020 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 16:45 UTC | OptimizeRx Corp OPRX · Entity 213 | Exercise / conversionStock Option · Derivative | 10,000 | $2.46 Strike: $2.46 | $24,600.00 |
DisclosureSEC source: 0001213900-20-025434 · ownership.xml · derivative · entry 3 BAKER DOUGLAS P · CIK 0001028775 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,559 Underlying: Common Stock · 10,000 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.